Skip to main content

LYPLAL1 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85245

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85245-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human LYPLAL1. Peptide sequence: EETNSMLKSLGVTTKFHSFPNVYHELSKTELDILKLWILTKLPGEMEKQK The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for LYPLAL1 Antibody

Western Blot: LYPLAL1 Antibody [NBP2-85245]

Western Blot: LYPLAL1 Antibody [NBP2-85245]

Western Blot: LYPLAL1 Antibody [NBP2-85245] - WB Suggested Anti-LYPLAL1 Antibody. Titration: 1.0 ug/ml. Positive Control: Placenta

Applications for LYPLAL1 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: LYPLAL1

Long Name

Lysophospholipase-like protein 1

Alternate Names

EC 3.1.2.-, FLJ99730, KIAA1238, lysophospholipase-like 1, lysophospholipase-like protein 1, Q96AV0

Gene Symbol

LYPLAL1

Additional LYPLAL1 Products

Product Documents for LYPLAL1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for LYPLAL1 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...